<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00711971</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00004684</org_study_id>
    <secondary_id>R21AT004166-01A1</secondary_id>
    <nct_id>NCT00711971</nct_id>
  </id_info>
  <brief_title>Does Fish Oil Prevent Depression in Pregnancy and Postpartum?</brief_title>
  <official_title>Does EPA or DHA Prevent Depressive Symptoms in Pregnancy and Postpartum?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to test whether an alternative medicine treatment, fish oil, will
      prevent depressive symptoms in pregnant and postpartum women who have been found to be at
      risk for depression. Epidemiologists have observed that people who live in countries where
      people on average eat a diet high in fish have a lower risk of depression than people who
      live in populations that eat less fish. Postpartum depression is also less common in these
      countries. The omega-3 fatty acids found in fish oil are thought to be responsible for this
      beneficial effect of eating fish. The two major omega-3 fatty acids found in fish are
      eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). DHA is an essential building
      block of the brain and nerve tissue. EPA may act to optimize the electrical signals between
      nerve cells and brain cells and may help the immune system to function well.

      Some researchers have treated people who are already suffering from depression with fish oil.
      Some of these studies have shown a benefit for the fish oil treatment and others have not.
      These studies have tested EPA and DHA alone and in various combinations. Currently, it is not
      known whether EPA or DHA is more effective in preventing and treating depression. Some of the
      researchers involved in this study have learned how to identify mothers who are most at risk
      for developing depression during and after pregnancy. This study is designed to learn whether
      EPA-rich and DHA-rich fish oil supplements will prevent depressive symptoms in women who are
      at risk to develop depression.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Beck Depression Inventory</measure>
    <time_frame>6 - 8 weeks postpartum</time_frame>
    <description>The Beck Depression inventory scores depression based on 21 items, with a score of 0 - 3 on each item where 0 is no depression and a score of 31 or more is clinically depressed. The 21 items were summed to obtain the total score (The maximum possible score is 63.)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Maternal Outcomes</measure>
    <time_frame>visits at 26 - 28 weeks gestational age, 34-36 weeks gestational age during pregnancy and at the post partum visit 6- 8 weeks after delivery</time_frame>
    <description>While the maternal outcomes assess criteria during pregnancy and relating to delivery they were assessed at visits 26 - 28 weeks gestational age, 34-36 weeks gestational age and at the post partum visit 6- 8 weeks after delivery.</description>
  </other_outcome>
  <other_outcome>
    <measure>Gestational Age at Delivery (Weeks)</measure>
    <time_frame>delivery date was assessed by medical record review between 1 day and 8 weeks after delivery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Estimated Blood Loss (ml)</measure>
    <time_frame>Within 24 hours after delivery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal Birthweight</measure>
    <time_frame>immediately after birth</time_frame>
    <description>Mean weight in grams: where &lt;2500 gm is considered small for gestational age and &gt;4500 gm is considered large for gestational age.</description>
  </other_outcome>
  <other_outcome>
    <measure>NICU (Neonatal Intensive Care Unit) Admissions</measure>
    <time_frame>6 weeks post delivery</time_frame>
    <description>Admission to the NICU</description>
  </other_outcome>
  <other_outcome>
    <measure>One Minute Apgar Score</measure>
    <time_frame>1 minute after birth</time_frame>
    <description>Apgar scores are based on a scale of 0 - 10 where 0 is a dead baby and 10 is an optimally vigorous newborn. The Apgar score analyzed here is the one minute Apgar.</description>
  </other_outcome>
  <other_outcome>
    <measure>Five Minute Apgar Score</measure>
    <time_frame>5 minutes after birth</time_frame>
    <description>Apgar scores are based on a scale of 0 - 10 where 0 is a dead baby and 10 is an optimally vigorous newborn. The Apgar score analyzed here is the five minute Apgar.</description>
  </other_outcome>
  <other_outcome>
    <measure>Cord Arterial pH</measure>
    <time_frame>Immediately after birth (collected within the first hour after delivery)</time_frame>
    <description>Arterial blood gas analysis of umbilical cord blood</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>EPA-rich fish oil supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EPA-rich fish oil supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA-rich fish oil supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>DHA-rich fish oil supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Soy Oil placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Soy oil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EPA-rich fish oil supplement</intervention_name>
    <description>1060 mg EPA plus 274 mg DHA</description>
    <arm_group_label>EPA-rich fish oil supplement</arm_group_label>
    <other_name>ProEPA Xtra</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DHA-rich fish oil supplement</intervention_name>
    <description>900 mg DHA plus 180 mg EPA</description>
    <arm_group_label>DHA-rich fish oil supplement</arm_group_label>
    <other_name>ProDHA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>control arm</description>
    <arm_group_label>Soy Oil placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women who are more than 12 weeks pregnant but less than 20 weeks pregnant

          -  Women who are found to be at risk for depression

          -  Women who have been treated for depression in the past

          -  Women with depression after a previous pregnancy

          -  Women planning to deliver at University of Michigan Hospital

        Exclusion Criteria:

          -  Women who have major depression or other psychiatric disorders (current substance
             abuse, schizophrenia, bipolar disorder) at the time of screening

          -  Women who are currently taking anti-depressant or other psychiatric medications

          -  Women who routinely eat more than 2 fish meals per week

          -  Women on anticoagulants (blood thinners)

          -  Women currently taking omega-3 fatty acid dietary supplements (fish oil, flaxseed oil
             or cod liver oil)

          -  Women with bleeding disorders such as von Willebrand's disease

          -  Women under the age of 18

          -  Women with a multiple gestation (twins, for example)

          -  Women planning to deliver at another hospital

          -  Women planning to move away before 6 weeks after delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen Mozurkewich, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mozurkewich E, Chilimigras J, Klemens C, Keeton K, Allbaugh L, Hamilton S, Berman D, Vazquez D, Marcus S, Djuric Z, Vahratian A. The mothers, Omega-3 and mental health study. BMC Pregnancy Childbirth. 2011 Jun 22;11:46. doi: 10.1186/1471-2393-11-46.</citation>
    <PMID>21696635</PMID>
  </reference>
  <results_reference>
    <citation>Mozurkewich EL, Greenwood M, Clinton C, Berman D, Romero V, Djuric Z, Qualls C, Gronert K. Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study. Front Pharmacol. 2016 Sep 7;7:274. doi: 10.3389/fphar.2016.00274. eCollection 2016.</citation>
    <PMID>27656142</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams JA, Romero VC, Clinton CM, Vazquez DM, Marcus SM, Chilimigras JL, Hamilton SE, Allbaugh LJ, Vahratian AM, Schrader RM, Mozurkewich EL. Vitamin D levels and perinatal depressive symptoms in women at risk: a secondary analysis of the mothers, omega-3, and mental health study. BMC Pregnancy Childbirth. 2016 Aug 3;16(1):203. doi: 10.1186/s12884-016-0988-7.</citation>
    <PMID>27485050</PMID>
  </results_reference>
  <results_reference>
    <citation>Romero VC, Somers EC, Stolberg V, Clinton C, Chensue S, Djuric Z, Berman DR, Treadwell MC, Vahratian AM, Mozurkewich E. Developmental programming for allergy: a secondary analysis of the Mothers, Omega-3, and Mental Health Study. Am J Obstet Gynecol. 2013 Apr;208(4):316.e1-6. doi: 10.1016/j.ajog.2013.01.024.</citation>
    <PMID>23531329</PMID>
  </results_reference>
  <results_reference>
    <citation>Mozurkewich EL, Clinton CM, Chilimigras JL, Hamilton SE, Allbaugh LJ, Berman DR, Marcus SM, Romero VC, Treadwell MC, Keeton KL, Vahratian AM, Schrader RM, Ren J, Djuric Z. The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial. Am J Obstet Gynecol. 2013 Apr;208(4):313.e1-9. doi: 10.1016/j.ajog.2013.01.038.</citation>
    <PMID>23531328</PMID>
  </results_reference>
  <results_reference>
    <citation>Ren J, Mozurkewich EL, Sen A, Vahratian AM, Ferreri TG, Morse AN, Djuric Z. Total Serum Fatty Acid Analysis by GC-MS: Assay Validation and Serum Sample Stability. Curr Pharm Anal. 2013;9(4):331-339.</citation>
    <PMID>25110470</PMID>
  </results_reference>
  <results_reference>
    <citation>Berman D, Clinton C, Limb R, Somers EC, Romero V, Mozurkewich E. Prenatal Omega-3 Supplementation and Eczema Risk among Offspring at Age 36 Months. Insights Allergy Asthma Bronchitis. 2016;2(1). pii: 1. doi: 10.21767/2471-304X.100014. Epub 2016 Apr 10.</citation>
    <PMID>28649675</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2008</study_first_submitted>
  <study_first_submitted_qc>July 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2008</study_first_posted>
  <results_first_submitted>November 2, 2016</results_first_submitted>
  <results_first_submitted_qc>March 17, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 28, 2017</results_first_posted>
  <last_update_submitted>March 17, 2017</last_update_submitted>
  <last_update_submitted_qc>March 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Ellen Mozurkewich</investigator_full_name>
    <investigator_title>Adjunct Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>EPA-rich Fish Oil Supplement</title>
          <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
        </group>
        <group group_id="P2">
          <title>DHA-rich Fish Oil Supplement</title>
          <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
        </group>
        <group group_id="P3">
          <title>Soy Oil Placebo</title>
          <description>Soy oil placebo: control arm</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="42"/>
                <participants group_id="P3" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All intent to treat - (all but lost to follow up) are included in baseline measures</population>
      <group_list>
        <group group_id="B1">
          <title>EPA-rich Fish Oil Supplement</title>
          <description>EPA-rich fish oil supplement
EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
        </group>
        <group group_id="B2">
          <title>DHA-rich Fish Oil Supplement</title>
          <description>DHA-rich fish oil supplement
DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
        </group>
        <group group_id="B3">
          <title>Soy Oil Placebo</title>
          <description>placebo: control arm</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="41"/>
            <count group_id="B4" value="118"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.9" spread="5.0"/>
                    <measurement group_id="B2" value="30.6" spread="4.5"/>
                    <measurement group_id="B3" value="30.4" spread="5.9"/>
                    <measurement group_id="B4" value="30.3" spread="5.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="41"/>
                    <measurement group_id="B4" value="118"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic-Latina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or other Pacific ethnicity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="41"/>
                    <measurement group_id="B4" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age at enrollment</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.9" spread="2.6"/>
                    <measurement group_id="B2" value="17" spread="2.3"/>
                    <measurement group_id="B3" value="16.2" spread="2.3"/>
                    <measurement group_id="B4" value="16.36" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity</title>
          <units>number of previous deliveries</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.87" spread="0.83"/>
                    <measurement group_id="B2" value="1.08" spread="0.94"/>
                    <measurement group_id="B3" value="0.85" spread="1.20"/>
                    <measurement group_id="B4" value="0.93" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Past history of depression(self reported)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BDI (Beck Depression Inventory) score</title>
          <description>Beck Depression Inventory contains self-reported answers to questions concerning depression symptoms. It has been validated for use with pregnant women. Minimum score is 0 with 0 as no depression and maximum score is 63 representing the most severe depression.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.41" spread="5.65"/>
                    <measurement group_id="B2" value="7.79" spread="5.29"/>
                    <measurement group_id="B3" value="7.15" spread="5.21"/>
                    <measurement group_id="B4" value="7.72" spread="5.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>EPDS Screen (Edinburgh Prenatal Depression Scale)</title>
          <description>The EPDS Screen is self-administered and subsequently scored by researchers on a 0 - 30 point range with 0 as no depression and 30 as most severe.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.93" spread="4.63"/>
                    <measurement group_id="B2" value="7.56" spread="4.49"/>
                    <measurement group_id="B3" value="7.34" spread="4.40"/>
                    <measurement group_id="B4" value="7.80" spread="4.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Beck Depression Inventory</title>
        <description>The Beck Depression inventory scores depression based on 21 items, with a score of 0 - 3 on each item where 0 is no depression and a score of 31 or more is clinically depressed. The 21 items were summed to obtain the total score (The maximum possible score is 63.)</description>
        <time_frame>6 - 8 weeks postpartum</time_frame>
        <population>Per protocol analysis is reported here.</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement
EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement
DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>Beck Depression Inventory</title>
          <description>The Beck Depression inventory scores depression based on 21 items, with a score of 0 - 3 on each item where 0 is no depression and a score of 31 or more is clinically depressed. The 21 items were summed to obtain the total score (The maximum possible score is 63.)</description>
          <population>Per protocol analysis is reported here.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BDI at 24-28 weeks' gestation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="3.7"/>
                    <measurement group_id="O2" value="6.5" spread="4.7"/>
                    <measurement group_id="O3" value="6.3" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BDI at 34-36 weeks' gestation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="5.0"/>
                    <measurement group_id="O2" value="5.9" spread="4.9"/>
                    <measurement group_id="O3" value="7.2" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BDI at 6-8 weeks postpartum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="5.2"/>
                    <measurement group_id="O2" value="5.1" spread="4.4"/>
                    <measurement group_id="O3" value="6.2" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Significance for the BDI test at 26-28 weeks</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.29</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Significance for BDI at 34-36 weeks gestation</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.51</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>BDI score at 6-8 weeks postpartum</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.56</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Maternal Outcomes</title>
        <description>While the maternal outcomes assess criteria during pregnancy and relating to delivery they were assessed at visits 26 - 28 weeks gestational age, 34-36 weeks gestational age and at the post partum visit 6- 8 weeks after delivery.</description>
        <time_frame>visits at 26 - 28 weeks gestational age, 34-36 weeks gestational age during pregnancy and at the post partum visit 6- 8 weeks after delivery</time_frame>
        <population>Gestational hypertension and diabetes were self-reported for all participants so her data is included for those two rows.
One woman in the soy placebo arm delivered out of the geographic area, so documentation of delivery outcome is unavailable for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement
EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement
DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil
placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>Maternal Outcomes</title>
          <description>While the maternal outcomes assess criteria during pregnancy and relating to delivery they were assessed at visits 26 - 28 weeks gestational age, 34-36 weeks gestational age and at the post partum visit 6- 8 weeks after delivery.</description>
          <population>Gestational hypertension and diabetes were self-reported for all participants so her data is included for those two rows.
One woman in the soy placebo arm delivered out of the geographic area, so documentation of delivery outcome is unavailable for analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Gestational Hypertension or Preeclampsia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gestational Diabetes Mellitus</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induced Labor</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cesarean Section</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spontaneous Vaginal Delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Operative Vaginal Delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Gestational diabetes mellitus</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.06</p_value>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Hypertension or preeclampsia</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.12</p_value>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Induced labor</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.20</p_value>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Cesarean section</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.08</p_value>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Spontaneous vaginal delivery</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.88</p_value>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Operative vaginal delivery</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.32</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Gestational Age at Delivery (Weeks)</title>
        <time_frame>delivery date was assessed by medical record review between 1 day and 8 weeks after delivery</time_frame>
        <population>Gestational age is measured based on the pregnancy not the neonates, therefore although there were 40 babies born to the 39 mothers randomized to the EPA-rich fish oil, it is proper to consider the participants analyzed to be the 39 participating mothers. This is clarified still further by identifying the units appropriately as pregnancies.</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age at Delivery (Weeks)</title>
          <population>Gestational age is measured based on the pregnancy not the neonates, therefore although there were 40 babies born to the 39 mothers randomized to the EPA-rich fish oil, it is proper to consider the participants analyzed to be the 39 participating mothers. This is clarified still further by identifying the units appropriately as pregnancies.</population>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>pregnancies</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>pregnancies</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.1" spread="1.5"/>
                    <measurement group_id="O2" value="40.4" spread="0.9"/>
                    <measurement group_id="O3" value="39.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Blood Loss (ml)</title>
        <time_frame>Within 24 hours after delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Blood Loss (ml)</title>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="507" spread="481"/>
                    <measurement group_id="O2" value="508" spread="325"/>
                    <measurement group_id="O3" value="454" spread="296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.81</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neonatal Birthweight</title>
        <description>Mean weight in grams: where &lt;2500 gm is considered small for gestational age and &gt;4500 gm is considered large for gestational age.</description>
        <time_frame>immediately after birth</time_frame>
        <population>Data is provided for all babies on whom delivery weights were available with a set of twins in EPA rich fish oil arm and a delivery elsewhere for whom no birth weight was available for one baby from a mother in the Soy oil placebo arm. Thus there is 1 more participant than mothers participating in the EPA-rich arm and one less in the soy oil arm.</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Birthweight</title>
          <description>Mean weight in grams: where &lt;2500 gm is considered small for gestational age and &gt;4500 gm is considered large for gestational age.</description>
          <population>Data is provided for all babies on whom delivery weights were available with a set of twins in EPA rich fish oil arm and a delivery elsewhere for whom no birth weight was available for one baby from a mother in the Soy oil placebo arm. Thus there is 1 more participant than mothers participating in the EPA-rich arm and one less in the soy oil arm.</population>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3402" spread="550"/>
                    <measurement group_id="O2" value="3774" spread="438"/>
                    <measurement group_id="O3" value="3309" spread="555"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <method>ANOVA</method>
            <method_desc>Kruskal-Wallis test was used for outliers; Tukey multiple comparisons test was also used.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>NICU (Neonatal Intensive Care Unit) Admissions</title>
        <description>Admission to the NICU</description>
        <time_frame>6 weeks post delivery</time_frame>
        <population>One set of twins in group A</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>NICU (Neonatal Intensive Care Unit) Admissions</title>
          <description>Admission to the NICU</description>
          <population>One set of twins in group A</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.39</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>One Minute Apgar Score</title>
        <description>Apgar scores are based on a scale of 0 - 10 where 0 is a dead baby and 10 is an optimally vigorous newborn. The Apgar score analyzed here is the one minute Apgar.</description>
        <time_frame>1 minute after birth</time_frame>
        <population>One set of twins from EPA group; Soy oil arm has data for only 40 as one baby was born elsewhere so Apgar data is not available.</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>One Minute Apgar Score</title>
          <description>Apgar scores are based on a scale of 0 - 10 where 0 is a dead baby and 10 is an optimally vigorous newborn. The Apgar score analyzed here is the one minute Apgar.</description>
          <population>One set of twins from EPA group; Soy oil arm has data for only 40 as one baby was born elsewhere so Apgar data is not available.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" spread="2.2"/>
                    <measurement group_id="O2" value="7.9" spread="1.8"/>
                    <measurement group_id="O3" value="7.9" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.19</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Five Minute Apgar Score</title>
        <description>Apgar scores are based on a scale of 0 - 10 where 0 is a dead baby and 10 is an optimally vigorous newborn. The Apgar score analyzed here is the five minute Apgar.</description>
        <time_frame>5 minutes after birth</time_frame>
        <population>One set of twins from EPA group; Soy oil arm has data for only 40 as one baby was born elsewhere so Apgar data is not available.</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>Five Minute Apgar Score</title>
          <description>Apgar scores are based on a scale of 0 - 10 where 0 is a dead baby and 10 is an optimally vigorous newborn. The Apgar score analyzed here is the five minute Apgar.</description>
          <population>One set of twins from EPA group; Soy oil arm has data for only 40 as one baby was born elsewhere so Apgar data is not available.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" spread="0.8"/>
                    <measurement group_id="O2" value="9.1" spread="0.2"/>
                    <measurement group_id="O3" value="8.9" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cord Arterial pH</title>
        <description>Arterial blood gas analysis of umbilical cord blood</description>
        <time_frame>Immediately after birth (collected within the first hour after delivery)</time_frame>
        <population>Umbilical cord gases (pH) were sent at the discretion of the delivering physician and so were not available for all participants.</population>
        <group_list>
          <group group_id="O1">
            <title>EPA-rich Fish Oil Supplement</title>
            <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
          </group>
          <group group_id="O2">
            <title>DHA-rich Fish Oil Supplement</title>
            <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
          </group>
          <group group_id="O3">
            <title>Soy Oil Placebo</title>
            <description>Soy oil placebo: control arm</description>
          </group>
        </group_list>
        <measure>
          <title>Cord Arterial pH</title>
          <description>Arterial blood gas analysis of umbilical cord blood</description>
          <population>Umbilical cord gases (pH) were sent at the discretion of the delivering physician and so were not available for all participants.</population>
          <units>pH</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.26" spread="0.09"/>
                    <measurement group_id="O2" value="7.27" spread="0.05"/>
                    <measurement group_id="O3" value="7.27" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.54</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 36 weeks (from enrollment at 12 - 20 weeks gestational age) through 6- 8 weeks after delivery</time_frame>
      <desc>The population listed as at risk here represents all 42 mothers randomized to each arm, but for NICU admissions and infant jaundice, the denominator (number at risk) represents the number of babies born to the mothers in each arm for whom data were available.</desc>
      <group_list>
        <group group_id="E1">
          <title>EPA-rich Fish Oil Supplement</title>
          <description>EPA-rich fish oil supplement: 1060 mg EPA plus 274 mg DHA</description>
        </group>
        <group group_id="E2">
          <title>DHA-rich Fish Oil Supplement</title>
          <description>DHA-rich fish oil supplement: 900 mg DHA plus 180 mg EPA</description>
        </group>
        <group group_id="E3">
          <title>Soy Oil Placebo</title>
          <description>Soy oil placebo: control arm</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Premature Delivery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>late miscarriage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Preterm premature rupture of membranes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Neonatal ICU Admission</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Postpartum hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Maternal ICU admission</sub_title>
                <description>Maternal ICU admission</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Infant Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="38"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Gestational Diabetes</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Aftertaste</sub_title>
                <description>Aftertaste (sometimes described as fishy, as lemon, as strawberry or just &quot;aftertaste&quot;</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Belching</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Loose stools</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>nausea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Heartburn</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>mastitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Preterm Contractions</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ellen Mozurkewich, Adjunct Assistant Professor</name_or_title>
      <organization>University of Michigan</organization>
      <phone>(734) 546-2772</phone>
      <email>emozurkewich@salud.unm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

